Colleen Riley serves as the SVP, Chief Technology Officer for embecta. Previously, Colleen was the Senior Vice President of Innovation and Development for Terumo Blood and Cell Technologies. Under Colleen’s leadership she advanced both existing and new product platforms beyond traditional scope of medical devices and therapy manufacturing to include services, software, and data management. These advancements drove continued growth throughout the particularly challenging COVID-19 pandemic.
Prior to that role, she served as Vice President Science and Technology and Vice President Regulatory Affairs and Compliance at Stryker Orthopedics. During this tenure, she led a regulatory transformation that delivered the pivotal Mako robotic clearances and expanded 3D printing capabilities. These initiatives led to optimized orthopedic implant design, improved functional outcomes and patient satisfaction, and drove market-leading growth. She also served as Vice President, Global Research for Novartis, AG, and Chief Operation Officer for Nexis Vision Inc. In both these roles, she led the organization into new white space, high growth opportunities, significantly increasing the value of their respective portfolios.
Colleen held several roles of increased responsibility at Johnson & Johnson Vision, including Vice President, Professional Development and Medical Affairs. Additionally, she was lead designer and developer of new product pipelines across multiple therapeutic categories. This included category altering products for both developed and emerging markets. Her efforts helped generate more than $2 billion in worldwide sales and market-leading growth.
A Doctor of Optometry, Colleen started her professional career in private practice, before joining the Indiana University School of Optometry as Clinical Faculty, Residency Program Supervisor and Co-Director of the Clinic. Colleen earned a Bachelor of Arts in Chemistry, a Master of Science in Physiological Optics and an OD, Doctor of Optometry, degree from Indiana University.